A new publication involving corticorelin related research appeared on November 11, 2026. The paper, titled "Prelimbic cortex CRHR1 regulates Parkinson's disease-related anxiety through a PrL(Glu)-avBNST(GABA)-VTA(DA) pathway," was published in Neuropharmacology. Corticorelin acts on CRHR1 receptors, which are the focus of this publication. The study is listed under PubMed ID 43014542. This brief reports only that the publication exists and the details provided about its title, journal, and date. No findings, results, or conclusions from the study are described here. Readers interested in the full scope of the research should consult the original publication directly. Corticorelin remains an approved compound, and this publication represents a new addition to the scientific literature referencing CRHR1 pathways relevant to Parkinson's disease related anxiety. For broader context on corticorelin, its approved status, and related background information, readers can refer to the compound overview.
New Publication Links CRHR1 Pathway to Parkinson's Anxiety
See the full corticorelin overview
Source: https://pubmed.ncbi.nlm.nih.gov/43014542/